The approval of Yesintek and Yesintek I.V., biosimilars to Stelara, strengthens Biocon Biologics’ presence in North America and expands its immunology portfolio
The approval of Yesintek and Yesintek I.V., biosimilars to Stelara, strengthens Biocon Biologics’ presence in North America and expands its immunology portfolio by Soban News (international And National News)